Organic Letters · 2019 · 55 citations · 24 references
MedicineMedicinal ChemistryMicrobiologyDrug DiscoveryDrug MetabolismMicrobial MetabolismAntibacterial AgentsAntibacterial PharmacologyAntifungal AgentsCytochrome P450 EnzymesDrug-metabolizing EnzymesMicrobial Natural Product BiosynthesisAntibiotic DiscoveryAntibiotic Mechanisms Of ActionAntifungal AntibioticsAntifungal ChemotherapyBiosynthetic Pathway ConstructionEpoxide Hydrolase ActivityEpoxide Hydrolase PathwaysMycobacterium Tuberculosis Infection
Atrovimycin (1), a cyclodepsipeptide containing a unique vicinal-hydroxylated cinnamic acyl chain, was isolated and elucidated from Streptomyces atrovirens LQ13. The biosynthetic pathway of 1 was achieved, revealing cytochrome P450 (Avm43) and epoxide hydrolase (Avm29) enzymes constructing the vicinal-dihydroxy substitution, as well as a tailoring P450 (Avm28) enzyme catalyzing β-hydroxylation of the l-Phe moiety. Atrovimycin shows in vitro antifungal activity and antitubercular activity against Mycobacterium tuberculosis H37Rv both in vitro (with MIC of 2.5 μg/mL) and in vivo.
24
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling, Tanja Schneider, Aaron J. Peoples et al. · Nature · 2015 · 2.4K citations · Full text
Human commensals producing a novel antibiotic impair pathogen colonization
Alexander Zipperer, Martin C. Konnerth, Claudia Laux et al. · Nature · 2016 · 940 citations
Optimized arylomycins are a new class of Gram-negative antibiotics
Peter A. Smith, Michael F. T. Koehler, Hany S. Girgis et al. · Nature · 2018 · 357 citations